19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Prevalence of signs of trachoma, ocular Chlamydia trachomatis infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          In some Pacific Island countries, such as Solomon Islands and Fiji, active trachoma is common, but ocular Chlamydia trachomatis ( Ct) infection and trachomatous trichiasis (TT) are rare. On Tarawa, the most populous Kiribati island, both the active trachoma sign “trachomatous inflammation—follicular” (TF) and TT are present at prevalences warranting intervention. We sought to estimate prevalences of TF, TT, ocular Ct infection, and anti- Ct antibodies on Kiritimati Island, Kiribati, to assess local relationships between these parameters, and to help determine the need for interventions against trachoma on Kiribati islands other than Tarawa.

          Methods

          As part of the Global Trachoma Mapping Project (GTMP), on Kiritimati, we examined 406 children aged 1–9 years for active trachoma. We collected conjunctival swabs (for droplet digital PCR against Ct plasmid targets) from 1–9-year-olds with active trachoma, and a systematic selection of 1–9-year-olds without active trachoma. We collected dried blood spots (for anti-Pgp3 ELISA) from all 1–9-year-old children. We also examined 416 adults aged ≥15 years for TT. Prevalence of TF and TT was adjusted for age (TF) or age and gender (TT) in five-year age bands.

          Results

          The age-adjusted prevalence of TF in 1–9-year-olds was 28% (95% confidence interval [CI]: 24–35). The age- and gender-adjusted prevalence of TT in those aged ≥15 years was 0.2% (95% CI: 0.1–0.3%). Twenty-six (13.5%) of 193 swabs from children without active trachoma, and 58 (49.2%) of 118 swabs from children with active trachoma were positive for Ct DNA. Two hundred and ten (53%) of 397 children had anti-Pgp3 antibodies. Both infection (p<0.0001) and seropositivity (p<0.0001) were strongly associated with active trachoma. In 1–9-year-olds, the prevalence of anti-Pgp3 antibodies rose steeply with age.

          Conclusion

          Trachoma presents a public health problem on Kiritimati, where the high prevalence of ocular Ct infection and rapid increase in seropositivity with age suggest intense Ct transmission amongst young children. Interventions are required here to prevent future blindness.

          Author summary

          Ocular infection with Chlamydia trachomatis causes trachoma. It is the leading infectious cause of blindness, and the target of an international campaign for elimination as a public health problem. Trachoma is endemic to Tarawa, the most populated island of Kiribati, housing approximately half the national population. However, the country has 20 inhabited islands and there were no previous trachoma prevalence data from Kiribati outside Tarawa. We set out to determine the prevalence of trachoma in the second most populated island, Kiritimati, located over 3000 km from Tarawa. In some other Pacific Island countries, ocular C. trachomatis infection is much less prevalent than the clinical signs that are used to guide interventions; we therefore looked for PCR-based evidence of current infection and antibodies to chlamydial proteins, in addition to recording clinical signs of trachoma. Our results indicate that trachoma and ocular C. trachomatis infection are prevalent on Kiritimati, and suggest that interventions are required here. The combined application of antibody, nucleic acid and clinical tools in an intervention-naïve population provides insight into their inter-relationships and the data are, therefore, of considerable interest to elimination programmes within and beyond the Pacific.

          Related collections

          Most cited references43

          • Record: found
          • Abstract: found
          • Article: not found

          A simple system for the assessment of trachoma and its complications.

          A simple grading system for trachoma, based on the presence or absence of five selected "key" signs, has been developed. The method was tested in the field and showed good observer agreement, the most critical point being the identification of severe cases of the disease. It is expected that the system will facilitate the assessment of trachoma and its complications by non-specialist health personnel working at the community level.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            The Global Trachoma Mapping Project: Methodology of a 34-Country Population-Based Study

            ABSTRACT Purpose: To complete the baseline trachoma map worldwide by conducting population-based surveys in an estimated 1238 suspected endemic districts of 34 countries. Methods: A series of national and sub-national projects owned, managed and staffed by ministries of health, conduct house-to-house cluster random sample surveys in evaluation units, which generally correspond to “health district” size: populations of 100,000–250,000 people. In each evaluation unit, we invite all residents aged 1 year and older from h households in each of c clusters to be examined for clinical signs of trachoma, where h is the number of households that can be seen by 1 team in 1 day, and the product h × c is calculated to facilitate recruitment of 1019 children aged 1–9 years. In addition to individual-level demographic and clinical data, household-level water, sanitation and hygiene data are entered into the purpose-built LINKS application on Android smartphones, transmitted to the Cloud, and cleaned, analyzed and ministry-of-health-approved via a secure web-based portal. The main outcome measures are the evaluation unit-level prevalence of follicular trachoma in children aged 1–9 years, prevalence of trachomatous trichiasis in adults aged 15 + years, percentage of households using safe methods for disposal of human feces, and percentage of households with proximate access to water for personal hygiene purposes. Results: In the first year of fieldwork, 347 field teams commenced work in 21 projects in 7 countries. Conclusion: With an approach that is innovative in design and scale, we aim to complete baseline mapping of trachoma throughout the world in 2015.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Strategies for control of trachoma: observational study with quantitative PCR.

              Antibiotics are an important part of WHO's strategy to eliminate trachoma as a blinding disease by 2020. At present, who needs to be treated is unclear. We aimed to establish the burden of ocular Chlamydia trachomatis in three trachoma-endemic communities in Tanzania and The Gambia with real-time quantitative PCR. Conjunctival swabs were obtained at examination from 3146 individuals. Swabs were first tested by the qualitative Amplicor PCR, which is known to be highly sensitive. In positive samples, the number of copies of omp1 (a single-copy C trachomatis gene) was measured by quantitative PCR. Children had the highest ocular loads of C trachomatis, although the amount of pooling in young age groups was less striking at the site with the lowest trachoma frequency. Individuals with intense inflammatory trachoma had higher loads than did those with other conjunctival signs. At the site with the highest prevalence of trachoma, 48 of 93 (52%) individuals with conjunctival scarring but no sign of active disease were positive for ocular chlamydiae. Children younger than 10 years old, and those with intense inflammatory trachoma, probably represent the major source of ocular C trachomatis infection in endemic communities. Success of antibiotic distribution programmes could depend on these groups receiving effective treatment.
                Bookmark

                Author and article information

                Contributors
                Role: ConceptualizationRole: InvestigationRole: Project administrationRole: SupervisionRole: Writing – original draft
                Role: InvestigationRole: Writing – original draft
                Role: Investigation
                Role: Data curationRole: Formal analysisRole: InvestigationRole: MethodologyRole: VisualizationRole: Writing – original draft
                Role: Investigation
                Role: Investigation
                Role: Investigation
                Role: Investigation
                Role: Data curationRole: Formal analysis
                Role: Funding acquisitionRole: Supervision
                Role: Data curationRole: Formal analysis
                Role: ConceptualizationRole: Supervision
                Role: Formal analysisRole: Writing – review & editing
                Role: MethodologyRole: Writing – review & editing
                Role: ConceptualizationRole: InvestigationRole: Project administrationRole: Supervision
                Role: ConceptualizationRole: Formal analysisRole: Funding acquisitionRole: InvestigationRole: MethodologyRole: SupervisionRole: Writing – original draftRole: Writing – review & editing
                Role: Editor
                Journal
                PLoS Negl Trop Dis
                PLoS Negl Trop Dis
                plos
                plosntds
                PLoS Neglected Tropical Diseases
                Public Library of Science (San Francisco, CA USA )
                1935-2727
                1935-2735
                12 September 2017
                September 2017
                : 11
                : 9
                : e0005863
                Affiliations
                [1 ] International Agency for the Prevention of Blindness, Western Pacific Region, Suva, Fiji
                [2 ] The Fred Hollows Foundation, Sydney, Australia
                [3 ] Centre for Eye Research, University of Melbourne, Melbourne, Australia
                [4 ] Eye Department, Ministry of Health and Medical Services, South Tarawa, Kiribati
                [5 ] Clinical Research Department, London School of Hygiene & Tropical Medicine, London, United Kingdom
                [6 ] Kiritimati Hospital, London, Kiritimati Island, Kiribati
                [7 ] International Trachoma Initiative, Task Force for Global Health, Decatur, Georgia, United States of America
                [8 ] MRC Tropical Epidemiology Group, Infectious Disease Epidemiology Department, London School of Hygiene & Tropical Medicine, London, United Kingdom
                [9 ] Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
                [10 ] Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland
                RTI International, UNITED STATES
                Author notes

                AC and RTLM of the Fred Hollows Foundation were personally involved in the study, as indicated in the statement of authors’ contributions; otherwise, funders had no role in project design, in project implementation or analysis or interpretation of data, in the decisions on where, how or when to publish in the peer reviewed press, or in preparation of the manuscript.

                ¶ Membership of The Global Trachoma Mapping Project is provided in the Acknowledgments.

                Author information
                http://orcid.org/0000-0003-0435-2655
                Article
                PNTD-D-17-00279
                10.1371/journal.pntd.0005863
                5609772
                28898240
                bd3a29fd-b21c-472e-9844-760bda3c8850
                Copyright @ 2017

                World Health Organization. Licensee Public Library of Science. This is an open access article distributed under the Creative Commons Attribution IGO License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/3.0/igo/. In any use of this article, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. This notice should be preserved along with the article’s original URL.

                History
                : 8 March 2017
                : 8 August 2017
                Page count
                Figures: 5, Tables: 2, Pages: 15
                Funding
                Funded by: Wellcome Trust (GB)
                Award ID: 098521
                Award Recipient :
                Funded by: Fred Hollows Foundation
                Award ID: 1954-0
                Award Recipient :
                Funded by: Department for International Development, UK Government (GB)
                Award ID: ARIES: 203145
                Award Recipient :
                Funded by: United States Agency for International Development (US)
                Award ID: AID-OAA-A-11-00048
                Award Recipient :
                Funded by: END
                Award ID: OAA-A-10-00051
                Award Recipient :
                This study was principally funded by the Global Trachoma Mapping Project (GTMP) grant from the United Kingdom’s Department for International Development (ARIES: 203145) to Sightsavers, which led a consortium of non-governmental organizations and academic institutions to support health ministries to complete baseline trachoma mapping worldwide; the Wellcome Trust (098521); and the Fred Hollows Foundation (ref 1954-0). The GTMP was also funded by the United States Agency for International Development, through the ENVISION project implemented by RTI International under cooperative agreement number AID-OAA-A-11-00048, and the END in Asia project implemented by FHI360 under cooperative agreement number OAA-A-10-00051. A committee established in March 2012 to examine issues surrounding completion of global trachoma mapping was initially funded by a grant from Pfizer to the International Trachoma Initiative. AWS was a Wellcome Trust Intermediate Clinical Fellow at the London School of Hygiene & Tropical Medicine, and is now a staff member of the World Health Organization. The authors alone are responsible for the views expressed in this article and they do not necessarily represent the views, decisions or policies of the institutions with which they are affiliated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
                Categories
                Research Article
                Medicine and Health Sciences
                Infectious Diseases
                Bacterial Diseases
                Trachoma
                Medicine and Health Sciences
                Ophthalmology
                Eye Diseases
                Trachoma
                Medicine and Health Sciences
                Tropical Diseases
                Neglected Tropical Diseases
                Trachoma
                Earth Sciences
                Geomorphology
                Topography
                Landforms
                Islands
                Medicine and Health Sciences
                Infectious Diseases
                Sexually Transmitted Diseases
                Chlamydia Infection
                People and Places
                Geographical Locations
                Oceania
                Kiribati
                Medicine and Health Sciences
                Ophthalmology
                Eye Diseases
                Biology and Life Sciences
                Physiology
                Immune Physiology
                Antibodies
                Medicine and Health Sciences
                Physiology
                Immune Physiology
                Antibodies
                Biology and Life Sciences
                Immunology
                Immune System Proteins
                Antibodies
                Medicine and Health Sciences
                Immunology
                Immune System Proteins
                Antibodies
                Biology and Life Sciences
                Biochemistry
                Proteins
                Immune System Proteins
                Antibodies
                Biology and Life Sciences
                Microbiology
                Medical Microbiology
                Microbial Pathogens
                Bacterial Pathogens
                Chlamydia Trachomatis
                Medicine and Health Sciences
                Pathology and Laboratory Medicine
                Pathogens
                Microbial Pathogens
                Bacterial Pathogens
                Chlamydia Trachomatis
                Biology and Life Sciences
                Organisms
                Bacteria
                Chlamydia
                Chlamydia Trachomatis
                Research and Analysis Methods
                Immunologic Techniques
                Immunoassays
                Enzyme-Linked Immunoassays
                Custom metadata
                vor-update-to-uncorrected-proof
                2017-09-22
                All relevant data are within the paper and its Supporting Information files.

                Infectious disease & Microbiology
                Infectious disease & Microbiology

                Comments

                Comment on this article